Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments
3D Printing Investing Organovo Announces Fiscal Third-Quarter 2017 Results; Company Updates Full-Year Fiscal 2017 Total Revenue Outlook
3D Printing Investing Organovo Announces Release Date for Fiscal Third-Quarter 2017 Financial Results
Organovo Presents First Preclinical Data on 3D Bioprinted Human Liver Tissues at TERMIS-Americas Meeting
3D Printing Investing Organovo Receives Strong Customer Response for ExVive Human Kidney Tissue Launch
3D Printing Investing Organovo Announces Release Date for Fiscal Second-Quarter 2017 Financial Results
3D Printing Investing Organovo Introduces 3D Bioprinted Human Liver as Leading Therapeutic Tissue in Preclinical Development
3D Printing Investing Organovo Presents Data Supporting 3D Bioprinted Liver Tissues for Drug Toxicity Testing and Liver Fibrosis Modeling
3D Printing Investing Organovo Holdings Announces Second Quarter 2016 Fiscal Results and Long-Range Outlooks
